Noveko Signs an Exclusive Agreement with Zer Hitech for Distribution in
Israel of its Antimicrobial Masks, Air Filtration Products and Hand
Sanitizers
Symbol: EKO / TSX
Following a thorough process, Zer Hitech was awarded by SAREL a contract to supply Noveko(TM) antimicrobial masks to health establishments throughout
Moreover, filters incorporating the Noveko(TM) antimicrobial filtration technology will soon be installed, through Zer Hitech, in a
"We are happy to be formalizing and strengthening our relationship with Zer Hitech, an ideal partner to promote and market our suite of antimicrobial technologies. We believe that this partnership, which is already bearing fruit, will also provide Noveko with additional long-term benefits as we are gaining a strong foothold in a country that has earned a reputation for being an international leader in the medical field. Furthermore, Zer Hitech's global network of distributors should facilitate our access to other countries," stated
Founded in 1976, Zer Group is a leading biotechnology company. Its affiliate, Zer Hitech, concentrates on fertility and infectious disease products. In addition, it represents leading companies in the field of medical supplies. Through Zer Laboratories, Zer Group also has a network of medical laboratories servicing hospitals, private laboratories and medical institutions throughout
Profile
Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technology, including air filters, surgical masks and respirators, along with other products with antibacterial properties such as Microban(R) brand hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.
Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements to account for new information, new events or new circumstances.
For further information: Chantal Vennat, Director, Investor Relations and Corporate Communications, Noveko International Inc., (514) 875-0606; http://www.noveko.com
Share this article